Literature DB >> 27603918

Thermoresponsive Collagen/Cell Penetrating Hybrid Peptide as Nanocarrier in Targeting-Free Cell Selection and Uptake.

Myungeun Oh1, Chloe Hu1, Selina F Urfano1, Merlyn Arostegui1, Katarzyna Slowinska1.   

Abstract

The effective delivery of therapeutics and imaging agents to a selected group of cells has been at the forefront of biomedical research. Unfortunately, the identification of the unique cell surface targets for cell selection remains a major challenge, particularly if cells within the selected group are not identical. Here we demonstrate a novel approach to cell section relying on a thermoresponsive peptide-based nanocarrier. The hybrid peptide containing cell-penetrating peptide (CPP) and collagen (COLL) domains is designed to undergo coil-to-helix transition (folding) below physiological temperature. Because only the helical form undergoes effective internalization by the cells, this approach allows effective temperature-discriminate cellular uptake. The cells selected for uptake are locally cooled, thus enabling the carrier to fold and subsequently internalize. Our approach demonstrates a generic method as selected cells could differ from the adjacent cells or could belong to the same cell population. The method is fast (<15 min) and selective; over 99.6% of cells in vitro internalized the peptide carrier at low temperatures (15 °C), while less than 0.2% internalized at 37 °C. In vivo results confirm the high selectivity of the method. The potential clinical applications in mixed cell differentiation carcinoma, most frequently encountered in breast and ovarian cancer, are envisioned.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27603918      PMCID: PMC5177025          DOI: 10.1021/acs.analchem.6b02438

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  48 in total

1.  c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma.

Authors:  A A Abou-Bakr; A Elbasmi
Journal:  Gulf J Oncolog       Date:  2013-07

2.  Local cooling reduces regional bone blood flow.

Authors:  Arne J Venjakob; Stephan Vogt; Klaus Stöckl; Thomas Tischer; Philipp J Jost; Eckart Thein; Andreas B Imhoff; Hermann Anetzberger
Journal:  J Orthop Res       Date:  2013-06-28       Impact factor: 3.494

Review 3.  Gpnmb/osteoactivin, an attractive target in cancer immunotherapy.

Authors:  L T Zhou; F Y Liu; Y Li; Y M Peng; Y H Liu; J Li
Journal:  Neoplasma       Date:  2012       Impact factor: 2.575

Review 4.  Antibody-drug conjugates: an emerging concept in cancer therapy.

Authors:  Ravi V J Chari; Michael L Miller; Wayne C Widdison
Journal:  Angew Chem Int Ed Engl       Date:  2014-02-20       Impact factor: 15.336

5.  Peptide internalization enabled by folding: triple helical cell-penetrating peptides.

Authors:  Aparna Shinde; Katie M Feher; Chloe Hu; Katarzyna Slowinska
Journal:  J Pept Sci       Date:  2014-12-18       Impact factor: 1.905

6.  Drug targeting using thermally responsive polymers and local hyperthermia.

Authors:  D E Meyer; B C Shin; G A Kong; M W Dewhirst; A Chilkoti
Journal:  J Control Release       Date:  2001-07-06       Impact factor: 9.776

Review 7.  Clinical role of FDG PET in evaluation of cancer patients.

Authors:  Lale Kostakoglu; Harry Agress; Stanley J Goldsmith
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

Review 8.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

9.  Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

Authors:  S Eckerle; V Brune; C Döring; E Tiacci; V Bohle; C Sundström; R Kodet; M Paulli; B Falini; W Klapper; A B Chaubert; K Willenbrock; D Metzler; A Bräuninger; R Küppers; M-L Hansmann
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  2 in total

1.  Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell Lines.

Authors:  Luladey Ayalew; Jessica Acuna; Selina F Urfano; Cristobal Morfin; Anthony Sablan; Myungeun Oh; Alicia Gamboa; Katarzyna Slowinska
Journal:  ACS Med Chem Lett       Date:  2017-07-27       Impact factor: 4.345

2.  Higher Order Architecture of Designer Peptides Forms Bioinspired 10 nm siRNA Delivery System.

Authors:  Alicia Gamboa; Selina F Urfano; Katrina Hernandez; Deborah A Fraser; Luladey Ayalew; Katarzyna Slowinska
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.